Literature DB >> 18193339

Family history of cancer in Brazil: is it being used?

Danilo V Viana1, Juvenal R N Góes, Cláudio S R Coy, Maria de Lourdes Setsuko Ayrizono, Carmen S P Lima, Iscia Lopes-Cendes.   

Abstract

In developing countries, low budgets make the issue of integrating genetics into clinical practice a challenge, a situation in which the use of family history (FH) becomes important for patient care, as it is a low cost strategy and a risk assessment tool. The purpose of this study was to review medical records of patients with colorectal cancer (CRC) seen in a public University Hospital and evaluate how often FH of cancer is registered. Initially we searched a database for patients who were seen in our hospital between 2002 and 2004 with the diagnosis of CRC. We found 415 patients, 104 of whom were excluded. A total of 311 charts were reviewed and classified into 3 groups. Group A: no FH documented; group B: FH was documented, but FH of cancer was not collected; and group C: FH of cancer was documented. We also investigated what type of information was recorded, in order to verify if important elements were assessed. Ninety-eight charts (31.5%) were classified in group A, 20 (6.5%) in group B, and 193 (62%) in group C. In addition, we observed that important information regarding affected relatives was not collected in most of the charts. In conclusion, we found that although FH of cancer was recorded in 62% of charts of patients with CRC, information that could be relevant for risk assessment and management of at-risk families was missing. Our findings expose an important problem in health education that could reflect negatively in the quality of medical assistance to individuals at risk for familial cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18193339     DOI: 10.1007/s10689-008-9180-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  22 in total

1.  Cancer family history and genetic testing: are malpractice adjudications waiting to happen?

Authors:  Henry T Lynch
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 2.  Reconsidering the family history in primary care.

Authors:  Eugene C Rich; Wylie Burke; Caryl J Heaton; Susanne Haga; Linda Pinsky; M Priscilla Short; Louise Acheson
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

Review 3.  Testing guidelines for hereditary non-polyposis colorectal cancer.

Authors:  Asad Umar; John I Risinger; Ernest T Hawk; J Carl Barrett
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model.

Authors:  Sharon Manne; Arnold Markowitz; Sidney Winawer; Jose Guillem; Neal J Meropol; Daniel Haller; Lina Jandorf; William Rakowski; James Babb; Terry Duncan
Journal:  Prev Med       Date:  2003-01       Impact factor: 4.018

5.  Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis.

Authors:  Scott D Ramsey; Wylie Burke; Linda Pinsky; Lauren Clarke; Polly Newcomb; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

6.  Identification and referral of families at high risk for cancer susceptibility.

Authors:  Kevin M Sweet; Terry L Bradley; Judith A Westman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

7.  A prospective study of family history and the risk of colorectal cancer.

Authors:  C S Fuchs; E L Giovannucci; G A Colditz; D J Hunter; F E Speizer; W C Willett
Journal:  N Engl J Med       Date:  1994-12-22       Impact factor: 91.245

8.  Family history in an oncology clinic. Implications for cancer genetics.

Authors:  H T Lynch; K L Follett; P M Lynch; W A Albano; J L Mailliard; R L Pierson
Journal:  JAMA       Date:  1979-09-21       Impact factor: 56.272

9.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

10.  Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

Authors:  Henry T Lynch; C Richard Boland; Miguel A Rodriguez-Bigas; Christopher Amos; Jane F Lynch; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

View more
  5 in total

1.  Knowledge about hereditary cancer of women with family histories of breast, colorectal, or both types of cancer.

Authors:  N Campacci; J O de Lima; L Ramadan; E I Palmero
Journal:  J Cancer Educ       Date:  2015-03       Impact factor: 2.037

2.  Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.

Authors:  Patrícia Koehler-Santos; Patricia Izetti; Jamile Abud; Carlos Eduardo Pitroski; Silvia Liliana Cossio; Suzi Alves Camey; Cláudio Tarta; Daniel C Damin; Paulo Carvalho Contu; Mario Antonello Rosito; Patricia Ashton-Prolla; João Carlos Prolla
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

3.  Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?

Authors:  Demétrius Eduardo Germini; Ana Maria Amaral Antônio Mader; Luiz Guilherme Lisboa Gomes; Thérèse Rachel Teodoro; Maria Isete Fares Franco; Jaques Waisberg
Journal:  Tumour Biol       Date:  2015-09-25

4.  A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Authors:  Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin
Journal:  BMC Cancer       Date:  2017-09-05       Impact factor: 4.430

5.  Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer.

Authors:  Natalia Campacci; Juliana O de Lima; André L Carvalho; Rodrigo D Michelli; Rafael Haikel; Edmundo Mauad; Danilo V Viana; Matias E Melendez; Fabiana de L Vazquez; Cleyton Zanardo; Rui M Reis; Benedito M Rossi; Edenir I Palmero
Journal:  Cancer Med       Date:  2017-10-21       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.